More than 23 million people older than 12 years of age suffer severe migraine headaches. The social and economic impact of migraines is staggering, with estimates approaching 17.2 billion per year lost in productivity.
Treatments for migraine headaches typically involve drugs such as Imitrex but now there is a promising new treatment recently approved by the FDA that uses no drugs. It’s called the NTI Suppression System (NTI-tss).
In clinical trials, the NTI-tss device considerably reduced or eliminated migraine and associated tension headache pain. It is considered breakthrough technology because there is no risk of side effects compared to pharmaceutical migraine treatments.
Patients who experience migraines typically contract their temporal muscles (which close and clench the jaw) during sleep on average 14 times more intensely than those who do not suffer migraines. Typical sufferers awake nearly every morning with varying degrees of headache pain but have come to accept it as normal and unremarkable.
The NTI-tss device is a small, removable device that fits over the front teeth only, which makes it easily tolerated for people who have a gag reflex problem. A dentist custom makes the device in the office, usually in one visit. The patient then wears it while sleeping. There is a daytime device available as well. With the NTI-tss device in place the intense activity of the temporal muscles is reduced by 1/3 by preventing contact between the back teeth. By reducing this neuromuscular activity, migraine attacks are reduced or prevented altogether, as well as the associated tension-type headaches.
One NTI-tss trial compared the effect of the device to a control device on medically diagnosed migraine sufferers. Each subject had at least 2 migraines per month and was taking physician prescribed Imitrex.
After just eight weeks of using the NTI-tss:
.There were no side-effects and no new pain
.82% of NTI-tss users had a 77% average reduction in migraine events
.Imitrex use was reduced by almost 50%
.Nausea episodes were reduced by 78%
.Light-sensitive episodes were reduced by 66%
.Sound sensitive episodes were reduced by 68%
General dentists can fabricate and deliver the NTI-tss device right in their offices. Many dentists across the country are already experienced with NTI-tss use after having been providing it over the past two years for the prevention of TMJ syndrome, clenching and grinding.

